A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo1
- 1 November 2005
- journal article
- Published by Springer Science and Business Media LLC in Acta Pharmacologica Sinica
- Vol. 26 (11), 1352-1358
- https://doi.org/10.1111/j.1745-7254.2005.00232.x
Abstract
APS (Acta Pharmacologica Sinica), the top pharmacology research journal based in China, publishes original articles and reviews on all aspects of pharmacology and the related life sciencesKeywords
This publication has 24 references indexed in Scilit:
- Synthesis and Immunosuppressive Activity of New Artemisinin Derivatives. 1. [12(β or α)-Dihydroartemisininoxy]phen(ox)yl Aliphatic Acids and EstersJournal of Medicinal Chemistry, 2005
- Inhibition ofS-Adenosyl-l-homocysteine Hydrolase Induces ImmunosuppressionThe Journal of pharmacology and experimental therapeutics, 2005
- Tolerance, not immunity, crucially depends on IL-2Nature Reviews Immunology, 2004
- Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responsesBlood, 2003
- Tolerance induction in clinical transplantation: the pending questionsTransplantation, 2003
- FK506 and cyclosporin, molecular probes for studying intracellular signal transductionImmunology Today, 1993
- Immunohistology of Human Allergic Late-Phase Skin ReactionsSkin Pharmacology and Physiology, 1991
- Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal miceInternational Journal of Immunopharmacology, 1990
- The chemistry, pharmacology, and clinical applications of qinghaosu (Artemisinin) and its derivativesMedicinal Research Reviews, 1987
- Qinghaosu (Artemisinin): an Antimalarial Drug from ChinaScience, 1985